Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,42299,95,1.81 [1.15-2.83],0.0100056139047716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE2,Angiotensin-converting enzyme 2,49383,114,1.42 [1.07-1.88],0.0141615484879484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP6,Lysophosphatidic acid phosphatase type 6,50655,120,0.76 [0.62-0.93],0.0076152563351977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",49383,114,1.55 [1.18-2.05],0.0018529994308326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY1,Aminoacylase-1,50298,118,1.37 [1.06-1.76],0.0153692166599854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,50851,119,1.55 [1.04-2.31],0.0305305364653602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,50008,119,1.93 [1.37-2.72],0.0001793321903415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,50919,116,0.48 [0.25-0.92],0.0283659741961389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,43751,100,1.99 [1.19-3.33],0.0083007450772385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,42800,100,1.41 [1.13-1.77],0.0027246140139978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,49383,114,1.27 [1.05-1.55],0.0138165542016553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADRA2A,Alpha-2A adrenergic receptor,42299,95,0.64 [0.43-0.95],0.0282456399935892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,50298,118,1.33 [1.09-1.61],0.0044631884765717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH1A1,Retinal dehydrogenase 1,50317,118,1.34 [1.01-1.76],0.0392058899998586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO2,Amphoterin-induced protein 2,50063,116,2.10 [1.05-4.22],0.0366075857131812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL4,Angiopoietin-related protein 4,50436,120,1.76 [1.25-2.50],0.0013751713172275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANPEP,Aminopeptidase N,50418,119,1.82 [1.06-3.11],0.0298585968253034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,49125,114,1.29 [1.09-1.53],0.0030997391881198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOF,Apolipoprotein F,43781,100,0.62 [0.38-0.99],0.046249383423771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,42326,94,1.33 [1.07-1.66],0.0103737201852023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNT,Aryl hydrocarbon receptor nuclear translocator,49349,116,0.59 [0.35-0.98],0.0435983223697162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,B2M,Beta-2-microglobulin,43812,101,1.42 [1.00-2.02],0.0481965604023639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,49115,114,1.35 [1.07-1.71],0.0131262502608294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BMPER,BMP-binding endothelial regulator protein,42800,100,2.09 [1.09-4.02],0.0271194174639044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,50746,120,1.71 [1.38-2.13],1.3129617659202622e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,50225,119,1.54 [1.06-2.24],0.0232963568773434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QA,Complement C1q subcomponent subunit A,50603,117,2.03 [1.01-4.10],0.0469796980607445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,50498,119,1.69 [1.21-2.37],0.0022114258470094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,42800,100,1.98 [1.19-3.29],0.0086706863156013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA9,Carbonic anhydrase 9,50729,120,1.53 [1.13-2.08],0.0055650107549813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,50729,120,1.52 [1.06-2.19],0.0235090559773653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD14,Monocyte differentiation antigen CD14,49284,117,1.59 [1.09-2.32],0.0157978145208317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD163,Scavenger receptor cysteine-rich type 1 protein M130,50498,119,1.44 [1.01-2.06],0.0458955723748877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,42299,95,1.46 [1.03-2.06],0.032676931479174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD209,CD209 antigen,50433,115,0.62 [0.41-0.95],0.0293335486896193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD300A,CMRF35-like molecule 8,42800,100,1.88 [1.03-3.42],0.0405979627957083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD302,CD302 antigen,50063,116,1.74 [1.07-2.83],0.0267544958116017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD34,Hematopoietic progenitor cell antigen CD34,50585,120,0.34 [0.17-0.66],0.0014685950587678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,50063,116,1.84 [1.13-3.00],0.0136665278072933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3G,T-cell surface glycoprotein CD3 gamma chain,42481,99,0.65 [0.46-0.93],0.0170583063932838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5L,CD5 antigen-like,43570,101,1.60 [1.08-2.35],0.0179075255846806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,42800,100,1.60 [1.06-2.41],0.0244421990982043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD74,HLA class II histocompatibility antigen gamma chain,50746,120,1.59 [1.03-2.46],0.0368598935133992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,43744,99,2.04 [1.25-3.33],0.0042846508726322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD86,T-lymphocyte activation antigen CD86,43557,98,1.96 [1.06-3.61],0.0311094274670666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH2,Cadherin-2,50298,118,1.57 [1.01-2.43],0.0443035345190649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,42949,99,1.46 [1.05-2.03],0.0227757965911148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,49349,116,1.25 [1.04-1.50],0.0157543719263611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES1,Liver carboxylesterase 1,50421,116,1.23 [1.02-1.48],0.0293389010033193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,49115,114,1.29 [1.00-1.65],0.0456314119339224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",43641,99,1.58 [1.07-2.35],0.0229519146671033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHIT1,Chitotriosidase-1,50509,116,1.16 [1.01-1.34],0.0320397180335777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",50103,120,1.36 [1.06-1.74],0.0146788544514612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC4A,C-type lectin domain family 4 member A,50225,119,0.57 [0.37-0.86],0.0070123690294707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC6A,C-type lectin domain family 6 member A,49115,114,1.41 [1.02-1.95],0.0374067945418727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLGN,Calmegin,42549,97,1.47 [1.04-2.06],0.0284295008857816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN1,Contactin-1,50919,116,0.54 [0.31-0.92],0.0246188833916894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTN5,Contactin-5,50425,120,0.64 [0.41-0.99],0.0459249783803575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,50512,115,2.28 [1.16-4.51],0.0172729216828281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL5A1,Collagen alpha-1(V) chain,42800,100,1.62 [1.05-2.49],0.0284561143340992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",42481,99,1.64 [1.00-2.69],0.0484809602876291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CPVL,Probable serine carboxypeptidase CPVL,50645,120,1.59 [1.06-2.41],0.0268160621155115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,49031,114,0.73 [0.60-0.89],0.0019324384170957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIM1,Cysteine-rich motor neuron 1 protein,50517,120,2.28 [1.07-4.88],0.0335451792156483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,49913,118,1.64 [1.19-2.27],0.0027756359860339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRNN,Cornulin,48856,118,0.74 [0.59-0.94],0.0118521293229674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAP,Cartilage-associated protein,42549,97,0.51 [0.29-0.88],0.0153880514044786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,43781,100,2.03 [1.37-3.01],0.0004255072568478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG4,Chondroitin sulfate proteoglycan 4,43751,100,2.20 [1.26-3.84],0.0055648244547808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,50413,119,1.92 [1.15-3.20],0.012707761755587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSF,Cathepsin F,50453,117,0.64 [0.43-0.96],0.0330398100483459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSL,Cathepsin L1,50298,118,2.24 [1.21-4.15],0.0104315521468118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,50851,119,2.13 [1.32-3.44],0.0019462383924802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXADR,Coxsackievirus and adenovirus receptor,50225,119,1.34 [1.00-1.80],0.047793282612701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL17,C-X-C motif chemokine 17,50851,119,1.45 [1.03-2.04],0.0331431909440213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,42186,96,1.34 [1.11-1.61],0.002091138657287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,50453,117,1.44 [1.08-1.93],0.0128261706938531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DKK4,Dickkopf-related protein 4,49831,118,1.42 [1.04-1.94],0.0271404566627512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,50571,120,1.35 [1.07-1.70],0.0122299245576298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,43667,97,1.94 [1.16-3.24],0.0117597374252925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",43744,99,1.43 [1.15-1.77],0.0012460560733347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFLAM,Pikachurin,43557,98,1.83 [1.10-3.03],0.0198798145684259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFR,Epidermal growth factor receptor,50919,116,0.53 [0.31-0.90],0.0196850690111186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPO,Erythropoietin,50225,119,1.23 [1.03-1.48],0.0258657230038964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ESM1,Endothelial cell-specific molecule 1,50268,120,1.66 [1.05-2.62],0.0286794184477417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,50611,117,1.42 [1.08-1.88],0.0131548469876439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF23,Fibroblast growth factor 23,50646,120,1.50 [1.22-1.85],0.0001046864636503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP1,Fibroblast growth factor-binding protein 1,50453,117,0.53 [0.33-0.84],0.0077737538102126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,50453,117,2.25 [1.12-4.50],0.0219746588672996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,43781,100,1.56 [1.18-2.07],0.0016702183704518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,49913,118,2.26 [1.36-3.75],0.0016347526564251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FTCD,Formimidoyltransferase-cyclodeaminase,43560,99,1.26 [1.02-1.56],0.0314738973272164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,42800,100,1.64 [1.24-2.15],0.0004400704042158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD8,Frizzled-8,42326,94,1.44 [1.03-2.00],0.0317547046754312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,50063,116,1.89 [1.07-3.33],0.0287324308861681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,43641,99,1.19 [1.06-1.35],0.0039930604302846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GBP1,Guanylate-binding protein 1,43562,99,1.40 [1.07-1.84],0.013674745228596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,50919,116,1.84 [1.41-2.39],5.248787802398368e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,50235,118,1.65 [1.26-2.17],0.0002816761920754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH2,Growth hormone variant,49115,114,1.09 [1.00-1.19],0.0487743899850555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,42186,96,1.56 [1.20-2.02],0.0008117246238132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPD1,Glycerol-3-phosphate dehydrogenase,43536,100,1.55 [1.13-2.14],0.0068895304072146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,43536,100,1.62 [1.30-2.02],2.1325309043914185e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",50063,116,1.54 [1.23-1.93],0.0001814610745785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSR,"Glutathione reductase, mitochondrial",43530,99,2.49 [1.12-5.52],0.0250959417017575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSTP1,Glutathione S-transferase P,48811,112,0.76 [0.58-0.99],0.0425022220411453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,50851,119,1.65 [1.08-2.53],0.0197781277062365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,50729,120,1.20 [1.06-1.35],0.0029223382404397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,42800,100,3.20 [1.62-6.30],0.0007772033770708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1R,Huntingtin-interacting protein 1-related protein,43559,99,1.44 [1.09-1.90],0.0097631049991589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HJV,Hemojuvelin,43667,97,1.44 [1.02-2.02],0.0372775691513378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",50069,117,1.91 [1.29-2.83],0.0012860152831128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,49924,119,1.84 [1.07-3.16],0.0277802844061162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,42500,97,1.89 [1.24-2.87],0.0029479009785398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP7,Insulin-like growth factor-binding protein 7,50919,116,1.71 [1.11-2.62],0.013992816074454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,49349,116,1.60 [1.06-2.42],0.0264568409193197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18R1,Interleukin-18 receptor 1,50851,119,1.94 [1.22-3.10],0.005379589350563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RAP,Interleukin-1 receptor accessory protein,50317,118,0.56 [0.38-0.83],0.0038997320383906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,49349,116,0.65 [0.42-0.99],0.0436715438288351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL4R,Interleukin-4 receptor subunit alpha,50225,119,1.66 [1.11-2.48],0.0126543950528723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,43536,100,1.52 [1.09-2.11],0.0134632103178521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBB,Inhibin beta B chain,42800,100,1.57 [1.12-2.19],0.0080513768477133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA11,Integrin alpha-11,50225,119,0.57 [0.36-0.91],0.0178438636681335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGAV,Integrin alpha-V,50729,120,0.34 [0.13-0.88],0.0265133885267366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGBL1,Integrin beta-like protein 1,43751,100,1.79 [1.16-2.77],0.0090770400961105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,50498,119,1.72 [1.12-2.65],0.0136019718725671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,50298,118,0.49 [0.33-0.74],0.0006334691938601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,49115,114,0.86 [0.77-0.97],0.0133607409079329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRB1,Killer cell lectin-like receptor subfamily B member 1,50851,119,1.59 [1.07-2.36],0.0222372771433861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",50063,116,1.30 [1.08-1.56],0.0046181675320392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,50268,120,1.38 [1.01-1.88],0.0452220328612272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LAMP3,Lysosome-associated membrane glycoprotein 3,50768,117,1.35 [1.00-1.82],0.047278845365892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LBP,Lipopolysaccharide-binding protein,50498,119,1.33 [1.01-1.74],0.0396437174764808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,43744,99,1.47 [1.13-1.92],0.0040949910659969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS4,Galectin-4,50268,120,1.33 [1.01-1.75],0.0414368852697387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS9,Galectin-9,50272,120,1.70 [1.06-2.73],0.0283875588339003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGMN,Legumain,50517,120,1.63 [1.06-2.50],0.0260548427560031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,49349,116,1.72 [1.22-2.44],0.0021449420591481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB2,Lamin-B2,43641,99,2.02 [1.12-3.64],0.0186019275783223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,48647,114,1.31 [1.01-1.70],0.0401209658691793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LRRC38,Leucine-rich repeat-containing protein 38,42549,97,1.41 [1.01-1.97],0.0447891929631278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP2,Latent-transforming growth factor beta-binding protein 2,50919,116,2.02 [1.25-3.26],0.0041184338987232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP3,Latent-transforming growth factor beta-binding protein 3,49115,114,1.33 [1.04-1.69],0.021351634670644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,49747,118,1.31 [1.03-1.68],0.0293285752413105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN2,Matrilin-2,50352,120,1.98 [1.16-3.38],0.0120216228087934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP4,Microfibril-associated glycoprotein 4,42800,100,2.21 [1.24-3.94],0.0070366087457562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MME,Neprilysin,50063,116,1.32 [1.09-1.60],0.0040884537741527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,43781,100,2.64 [1.45-4.78],0.0014376766495042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,50746,120,1.64 [1.16-2.31],0.0048046123747333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,49349,116,1.24 [1.02-1.50],0.0301561142034779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,42800,100,2.80 [1.19-6.60],0.0185324848949408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAM2,Neural cell adhesion molecule 2,50317,118,0.45 [0.25-0.83],0.0104857823186411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAN,Neurocan core protein,50746,120,0.51 [0.34-0.77],0.0014609964444888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,43557,98,1.90 [1.12-3.21],0.0165448625335649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDRG1,Protein NDRG1,49125,114,0.70 [0.50-0.99],0.0413967463299583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEB,Nebulin,42299,95,1.51 [1.05-2.18],0.0279101009776916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,48970,114,1.97 [1.50-2.58],8.31574102786701e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,50336,119,1.56 [1.03-2.36],0.0345701756846497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS3,"Nitric oxide synthase, endothelial",49125,114,1.37 [1.08-1.74],0.0089073068209845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,43011,98,1.93 [1.24-3.00],0.0037785671483307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPL,N-acetylneuraminate lyase,43744,99,1.55 [1.05-2.27],0.0257942229390307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPPB,Natriuretic peptides B,49383,114,1.14 [1.01-1.29],0.0390686906629804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRTN,Neurturin,49349,116,1.33 [1.02-1.74],0.0374081637772397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRXN3,Neurexin-3,42549,97,0.41 [0.19-0.88],0.0224863631248615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C1A,Cytosolic 5'-nucleotidase 1A,43641,99,1.67 [1.08-2.59],0.0201539883295499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,50453,117,1.63 [1.27-2.08],9.792235348929446e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF3,Neurotrophin-3,50225,119,1.71 [1.16-2.52],0.006822805304513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTproBNP,N-terminal prohormone of brain natriuretic peptide,50298,118,1.20 [1.05-1.38],0.0075684938782615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,43667,97,1.70 [1.16-2.49],0.0066377469671033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM2,Paralemmin-2,43641,99,2.03 [1.36-3.03],0.0004952992588271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,42719,100,1.67 [1.17-2.37],0.0044754976375812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA3,Protein disulfide-isomerase A3,42800,100,1.74 [1.01-3.01],0.0472764586143618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,42481,99,1.55 [1.08-2.23],0.018276521410318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PFDN4,Prefoldin subunit 4,42186,96,0.53 [0.33-0.84],0.0066670088365869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,42800,100,1.61 [1.02-2.53],0.0403943947422143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIGR,Polymeric immunoglobulin receptor,49660,118,1.59 [1.04-2.42],0.0313667697051273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,50453,117,2.25 [1.28-3.96],0.0046859188681027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,50672,116,2.10 [1.10-3.98],0.0237840257934038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PON3,Serum paraoxonase/lactonase 3,50517,120,0.66 [0.50-0.88],0.0047992414071421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPY,Pancreatic prohormone,50221,116,1.18 [1.01-1.37],0.0401259735796321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PREB,Prolactin regulatory element-binding protein,49349,116,1.56 [1.01-2.40],0.0442129542516316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,43337,99,2.29 [1.49-3.53],0.0001536833332765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,43744,99,2.49 [1.37-4.51],0.0027093187340033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,48891,113,1.54 [1.18-2.00],0.0012972060226393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,42326,94,1.35 [1.08-1.70],0.0091267201281821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEPK,Rab9 effector protein with kelch motifs,49115,114,1.29 [1.01-1.64],0.0374009656349988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RANGAP1,Ran GTPase-activating protein 1,49115,114,0.63 [0.41-0.96],0.0315068054434554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCC1,Regulator of chromosome condensation,43536,100,1.39 [1.06-1.84],0.0177711388136791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,42800,100,1.50 [1.06-2.12],0.0209256371687886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,43781,100,2.14 [1.28-3.56],0.0036539994515698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,43466,99,1.87 [1.32-2.64],0.0003743568237158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RRM2,Ribonucleoside-diphosphate reductase subunit M2,49115,114,1.36 [1.09-1.69],0.0071689126040062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A3,Protein S100-A3,43536,100,0.42 [0.20-0.85],0.0169189899045801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAA4,Serum amyloid A-4 protein,43812,101,1.48 [1.04-2.09],0.0285282513067231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAP18,Histone deacetylase complex subunit SAP18,42949,99,0.72 [0.55-0.95],0.0214469320701967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAT2,Thialysine N-epsilon-acetyltransferase,42949,99,0.69 [0.49-0.97],0.033005118301731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,48955,113,1.98 [1.28-3.06],0.0022786603300056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,50582,119,1.77 [1.30-2.40],0.0002720669099987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,50298,118,1.72 [1.20-2.46],0.0029031499440718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,50754,116,1.71 [1.05-2.78],0.030885567282064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHISA5,Protein shisa-5,43751,100,1.94 [1.18-3.17],0.0086547797303575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,50225,119,1.69 [1.12-2.56],0.0132410478651528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,49115,114,1.57 [1.07-2.30],0.0213562967680207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF7,SLAM family member 7,50225,119,1.31 [1.01-1.71],0.0452212493562301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,49125,114,1.28 [1.02-1.62],0.0364977315858074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLITRK6,SLIT and NTRK-like protein 6,49383,114,0.60 [0.37-0.98],0.0427767539853217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNU13,NHP2-like protein 1,42299,95,0.55 [0.34-0.88],0.0122867697889458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX5,Sorting nexin-5,42584,98,0.37 [0.17-0.80],0.0115446029517801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD2,"Superoxide dismutase [Mn], mitochondrial",50317,118,1.50 [1.02-2.21],0.0374429292881849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK4,Serine protease inhibitor Kazal-type 4,50225,119,1.29 [1.03-1.62],0.0265239458687509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",50919,116,1.73 [1.09-2.73],0.0193557891854353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD5,Sushi domain-containing protein 5,42559,99,1.81 [1.04-3.14],0.0356239990847529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,50067,118,1.29 [1.09-1.54],0.0040321490372537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,50436,120,1.47 [1.15-1.89],0.0023737425702233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI2,Tissue factor pathway inhibitor 2,50301,117,1.36 [1.02-1.80],0.0362758890307186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,42299,95,1.20 [1.05-1.38],0.0067119159772261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,49754,119,2.03 [1.23-3.33],0.0053891340870758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TINAGL1,Tubulointerstitial nephritis antigen-like,50141,118,2.17 [1.06-4.46],0.0348191717526681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNC,Tenascin,50498,119,1.49 [1.08-2.06],0.0162658458080553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNF,Tumor necrosis factor,49306,114,1.38 [1.00-1.92],0.0494159971931734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,49913,118,1.75 [1.16-2.65],0.008205496241705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,50352,120,1.74 [1.27-2.39],0.000644027293418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,42800,100,1.58 [1.01-2.46],0.0434350438475708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,50317,118,1.52 [1.12-2.05],0.0068086413397256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,50746,120,1.44 [1.04-1.98],0.0267548995251583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13,Tumor necrosis factor ligand superfamily member 13,50517,120,1.82 [1.02-3.25],0.0421006241570632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPP1,Tripeptidyl-peptidase 1,49933,119,1.36 [1.00-1.84],0.0468394371435776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM21,E3 ubiquitin-protein ligase TRIM21,50225,119,0.81 [0.67-0.98],0.0266693533899622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UMOD,Uromodulin,50758,116,0.68 [0.52-0.90],0.0072466427293782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VAMP5,Vesicle-associated membrane protein 5,49383,114,1.34 [1.06-1.69],0.0158561914207663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAM1,Vascular cell adhesion protein 1,50417,119,1.98 [1.13-3.44],0.0161753125446971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAN,Versican core protein,50746,120,1.72 [1.04-2.85],0.0347974341221603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN2,Vascular non-inflammatory molecule 2,50063,116,1.49 [1.03-2.17],0.0337854937443482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSNL1,Visinin-like protein 1,43641,99,1.51 [1.01-2.28],0.0472620242624976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VWF,von Willebrand factor,50919,116,1.25 [1.00-1.55],0.0499995088333711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WARS,"Tryptophan--tRNA ligase, cytoplasmic",50317,118,1.62 [1.07-2.47],0.0234968860756888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC2,WAP four-disulfide core domain protein 2,47743,113,1.50 [1.04-2.17],0.031991640878606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB17,Zinc finger and BTB domain-containing protein 17,49383,114,1.46 [1.10-1.95],0.0094000992226285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZPR1,Zinc finger protein ZPR1,42326,94,1.19 [1.01-1.40],0.0390792710077328
